Clinical Trial Update: A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a combined single-ascending-dose (Part A) and repeat-dose (Part B) study of UCB1381 to assess safety, pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• UCB1381

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED